Global loss of Na,K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis

Journal of Neuroscience

Volumn 23, Issue 1, 2003, Pages 43-51

  Ellis, Dorette Z ^a   Rabe, Jason ^a   Sweadner, Kathleen J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Amyotrophic lateral sclerosis; Na,K ATPase; Neurodegeneration; Nitric oxide; SOD1; Spinal cord

Indexed keywords

8 BROMO CYCLIC AMP; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); NITRIC OXIDE; PROTEIN KINASE C ACTIVATOR; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBUNIT; EPENDYMA CELL; EXPERIMENTAL MODEL; FEMALE; GENE MUTATION; GLIA; MALE; MOUSE; MYELINATED NERVE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REGULATORY MECHANISM; SPINAL CORD; TISSUE SLICE; TRANSGENIC MOUSE;

EID: 0037221596     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-01-00043.2003     Document Type: Article

References (71)

1. Almer G, Vukosavic S, Romero N, Przedborski S (1999) Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 72:2415-2425.
2. Ames III A (2000) CNS energy metabolism as related to function. Brain Res Brain Res Rev 34:42-68.
3. Andrus PK, Fleck TJ, Gurney ME, Hall ED (1998) Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 71:2041-2048.
4. Barkats M, Bertholet J-Y, Venault P, Ceballos-Picot I, Nicole A, Phillips J, Moutier R, Roubertoux P, Sinet PM, Cohen-Salmon M (1993) Hippocampal mossy fiber changes in mice transgenic for the human copper/zinc superoxide dismutase gene. Neurosci Lett 160:24-28.
5. Bar-Peled O, Korkotian E, Segal M, Groner Y (1996) Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic Cu/Zn superoxide dismutase neurons. Proc Natl Acad Sci USA 93:8530-8535.
6. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366.
7. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am J Physiol 271:C1424-C1437.
8. Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS, SOD, and peroxynitrite. Nature 364:584.
9. Blanco G, Mercer RW (1998) Isozymes of the Na-K-ATPase: Heterogeneity in structure, diversity in function. Am J Physiol 275:F633-F650.
10. Boldyrev AA, Bulygina ER, Kramarenko GG, Vanin AF (1997) Effect of nitroso compounds on Na/K-ATPase. Biochim Biophys Acta 1321:243-251.
11. Brines ML, Robbins RJ (1992) Inhibition of α2/α3 sodium pump isoforms potentiates glutamate neurotoxicity. Brain Res 591:94-102.
12. Brines ML, Dare AO, de Lanerolle NC (1995) The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus. Neurosci Lett 191:145-148.
13. Brown Jr RH (1995) Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice. Cell 80:687-692.
14. Browne SE, Bowling AC, Baik MJ, Gurney ME, Brown Jr RH, Beal MF (1998) Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J Neurochem 71:281-287.
15. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338.
16. Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281:1851-1854.
17. +-ATPase. Eur J Neurosci 7:1674-1683.
18. Ceballos-Picot I, Nicole A, Briand P, Grimber G, Delacourte A, Defossez A, Javoy-Agid F, Lafon M, Blouin JL, Sinet PM (1991) Neuronal-specific expression of human copper/zinc superoxide dismutase gene in transgenic mice: Animal model of gene dosage effects in Down's syndrome. Brain Res 552:198-214.
19. Chiueh CC (1999) Neuroprotective properties of nitric oxide. Ann NY Acad Sci 890:301-311.
20. Cleveland DW, Rothstein JD (2001) From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2:806-819.
21. Crambert G, Hasler U, Beggah AT, Yu C, Modyanov NN, Horisberger J-D, Lelievre L, Geering K (2000) Transport and pharmacological properties of nine different human Na,K-ATPase isozymes. J Biol Chem 275:1976-1986.
22. Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JS (1997) Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration of peroxynitrite. J Neurochem 69:1936-1944.
23. Dawson TM, Dawson VL, Snyder SH (1992) A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann Neurol 32:297-311.
24. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371.
25. Diodati JG, Quyyumi AA, Keefer LK (1993) Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: Hemodynamic effects in rabbit. J Cardiovasc Pharmacol 22:287-292.
26. +-ATPase activity in choroid plexus via stimulation of the NO/cGMP pathway. Am J Physiol 279:C1685-C1693.
27. Ellis DZ, Nathanson JA, Rabe J, Sweadner KJ (2001) Carbachol and NO inhibit Na,K-ATPase in ciliary process via activation of guanylate cyclase and cGMP. Invest Ophthalmol Vis Sci 42:2625-2631.
28. Facchinetti F, Sasaki M, Cutting FB, Zhai P, MacDonald JE, Reif D, Beal MF, Huang PL, Dawson TM, Gurney ME, Dawson VL (1999) Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis. Neuroscience 90:1483-1492.
29. Gahtan E, Auerbach JM, Groner Y, Segal M (1998) Reversible impairment of long-term potentiation in transgenic Cu/Zn SOD mice. Eur J Neurosci 10:538-544.
30. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-I-one. Mol Pharmacol 48:184-188.
31. Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL (2000) Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20:660-665.
32. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng H-X, Chen W, Zhai P, Sufit L, Siddique T (1994) Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 264:1772-1775.
33. Hieber V, Siegel GJ, Fink DJ, Beaty MW, Mata M (1991) Differential distribution of (Na,K)-ATPase α isoforms in the central nervous system. Cell Mol Neurobiol 11:253-262.
34. +)-ATPase: Inactivation and degradation induced by oxygen radicals. Int J Biochem 24:621-626.
35. Julien J-P (2001) Amyotrophic lateral sclerosis: Unfolding the toxicity of the misfolded. Cell 104:581-591.
36. +-ATPase. Am J Physiol 252:H252-H257.
37. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daowk R, Beal MF (1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 3:347-350.
38. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364:535-537.
39. Lee M, Hyun D-H, Jenner P, Halliwill B (2001) Effect of overexpression of wild-type and mutant Cu/Zn superoxide dismutases on oxidative damage and antioxidant defenses: Relevance to Down's syndrome and familial amyotrophic lateral sclerosis. J Neurochem 76:957-965.
40. +-ATPase inhibitor ouabain in causing neuronal lesions in the rat hippocampus. Brain Res 714:145-155.
41. Lees GJ, Lehmann A, Sandberg M, Hamberger A (1990) The neurotoxicity of ouabain, a sodium/potassium ATPase inhibitor, in the rat hippocampus. Neurosci Lett 120:159-162.
42. Lino MM, Schneider C, Caroni P (2002) Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22:4825-4832.
43. Lipton SA, Choi Y-B, Pan Z-H, Lei SZ, Chen H-S, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso compounds. Nature 364:626-632.
44. Martin-Vasallo P, Wetzel RK, Garcia-Segura LM, Molina-Holgado E, Arystarkhova E, Sweadner KJ (2000) Oligodendrocytes in brain and optic nerve express the β3 subunit isoform of Na,K-ATPase. Glia 31:206-218.
45. Mata M, Siegel GJ, Hieber V, Beaty MW, Fink DJ (1991) Differential distribution of (Na,K)-ATPase α isoform mRNAs in the peripheral nervous system. Brain Res 546:47-54.
46. McGrail KM, Phillips JM, Sweadner KJ (1991) Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: Both neurons and glia can express more than one Na,K-ATPase. J Neurosci 11:381-391.
47. McKee M, Scavone C, Nathanson JA (1994) Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 91:12056-12060.
48. McLean IW, Nakane PK (1974) Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J Histochem Cytochem 22:1077-1083.
49. Mense M, Stark G, Apell H-J (1997) Effects of free radicals on partial reactions of the Na,K-ATPase. J Membr Biol 156:63-71.
50. Murad F (1998) Nitric oxide signaling: Would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? Recent Prog Horm Res 53:43-59.
51. + pump as a site of action for carbon monoxide and glutamate: A mechanism for long-term modulation of cellular activity. Neuron 14:781-794.
52. Peng L, Martin-Vasallo P, Sweadner KJ (1997) Isoforms of Na,K-ATPase α and β subunits in the rat cerebellum and in granule cell cultures. J Neurosci 17:3488-3502.
53. Pramatarova A, Laganiere J, Roussel J, Brisebois K, Rouleau GA (2001) Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21:3369-3374.
54. + changes induced by glutamate, kainate, and D-aspartate in rat hippocampal astrocytes. J Neurosci 16:5393-5404.
55. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, Gusella JS, Horvitz HR, Brown Jr RH (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62.
56. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW (1993) Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 90:6591-6595.
57. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38:73-84.
58. Samdani AF, Newcamp C, Resink A, Facchinetti F, Hoffman BE, Dawson VL, Dawson TM (1997) Differential susceptibility to neurotoxicity mediated by neurotrophins and neuronal nitric oxide synthase. J Neurosci 17:4633-4641.
59. Sato T, Kamata Y, Irifune M, Nishikawa T (1997) Inhibitory effect of several nitric oxide-generating compounds on purified Na,K-ATPase activity from porcine cerebral cortex. J Neurochem 68:1312-1318.
60. Scavone C, Scanlon C, McKee M, Nathanson JA (1995) Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase. J Pharmacol Exp Ther 272:1036-1043.
61. Stadtman ER (1992) Protein oxidation and aging. Science 257:1220-1224.
62. Stamler JS, Singel DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898-1902.
63. +-ATPase in neuro-glial cell cultures of cerebellum induces glutamate-dependent damage of granule cells. FEBS Lett 456:41-44.
64. +-ATPase. Biochim Biophys Acta 988:185-220.
65. +-ATPase through proteasomal and endo-/lysosomal/proteolytic pathways. FASEB J 13:1751-1761.
66. Trotti D, Rolfs A, Danbolt NC, Brown Jr RH, Hediger MA (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 2:427-433.
67. Viani P, Cervato G, Fiorilli A, Cestaro B (1991) Age-related differences in synaptosomal peroxidative damage and membrane properties. J Neurochem 56:253-258.
68. +-ATPase α- and β-subunit isoforms within the rat central nervous system. Proc Natl Acad Sci USA 88:7425-7429.
69. Wetzel RK, Arystarkhova E, Sweadner KJ (1999) Cellular and subcellular specification of Na,K-ATPase α and β isoforms in the postnatal development of mouse retina. J Neurosci 19:9878-9889.
70. +ATPase expressed in baculovirus-infected insect cells. Biochem Biophys Res Commun 207:155-159.
71. Zolotarjova N, Ho C, Mellgren RL, Askari A, Huang W-H (1994) Different sensitivities of native and oxidized forms of Na,K-ATPase to intracellular proteinases. Biochim Biophys Acta 1192:125-131.